Germany BMBF GO-Bio next
Supports Germany BMBF GO-Bio next as a biotech transfer route for life-science researchers entering venture formation.
Germany BMBF GO-Bio next sits under the Federal Ministry for Research, Technology and Space as a biotech transfer route for early-stage life-sciences entrepreneurs. It is designed for research that is ready to move toward start-up formation, so the core logic is not basic discovery alone but the handoff from research into a company setting. The instrument is a grant, with awards from €535,000 to €5.35 million. The program is annual, limited to Germany, and excludes individuals. It does not require a multi-party consortium, which leaves room for a focused German team that can advance a transfer project without building a large coalition first. GO-Bio next is strongest where a life-sciences team has a clear commercial path, a defined technical milestone, and a credible case for public support before private capital is ready. The size of the award range suggests a program meant to carry a project through the expensive early bridge between lab results and a first company structure.
No upcoming rounds verified. Cadence: Annual.